Classification of intracranial pressure epochs using a novel machine learning framework
- PMID: 40210973
- PMCID: PMC11986046
- DOI: 10.1038/s41746-025-01612-3
Classification of intracranial pressure epochs using a novel machine learning framework
Abstract
Patients with acute brain injuries are at risk for life threatening elevated intracranial pressure (ICP). External Ventricular Drains (EVDs) are used to measure and treat ICP, which switch between clamped and draining configurations, with accurate ICP data only available during clamped periods. While traditional guidelines focus on mean ICP values, evolving evidence indicates other waveform features may hold prognostic value. However, current machine learning models using ICP waveforms exclude EVD data due to a lack of digital labels indicating the clamped state, markedly limiting their generalizability. We introduce, detail, and validate CICL (Classification of ICP epochs using a machine Learning framework), a semi-supervised approach to classify ICP segments from EVDs as clamped, draining, or noise. This paves the way for multiple applications, including generalizable ICP crisis prediction, potentially benefiting tens of thousands of patients annually and highlights an innovate methodology to label large high frequency physiological time series datasets.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing financial or non-financial interests that have a relationship to this work as defined by Nature Portfolio. The authors declare the following non-competing disclosures: Vishank Shah disclosures: VS received honoraria (<1000$) from Astra Zeneca and serves on the Editorial Board for Neurohospitalist. Sudha Yellapantula works as a Researcher for Medical Informatics Corp (MIC, Houston TX) and reports no competing interests. MIC is a company that provides the Sickbay platform to various hospitals, for clinical and research use of the data. Medical Informatics provided no funding and/or support for the study. Jose I Suarez disclosures: ex-officio member of the Board of Directors of the Neurocritical Care Society; member of the Scientific Advisory Board for Cyban; Member of the Data Safety Monitoring Board for clinical trials sponsored by Acasti and Perfuze; member of the Advisory Board for AstraZeneca for Andexxa Medical Strategy. Susanne Muehlschlegel disclosures: ex-officio member of the Board of Directors of the Neurocritical Care Society; Consultant for Acasti Pharma as a member of the clinical endpoint adjudication committee. Has received speaking and writing honoraria from the American Academy of Neurology. Serves on the Editorial Board for Neurocritical Care and Stroke (unpaid).
Figures
References
-
- Le Roux, P. et al. Consensus summary statement of the international multidisciplinary consensus conference on multimodality monitoring in neurocritical care: a statement for healthcare professionals from the neurocritical care society and the european society of intensive care medicine. Neurocritical Care21, 1–26 (2014). - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
